Baxter International (BAX) EBIT Margin (2009 - 2026)

Baxter International (BAX) has 18 years of EBIT Margin data on file, last reported at 2.44% in Q1 2026.

• On a quarterly basis, EBIT Margin rose 23.0% year-over-year to 2.44% in Q1 2026; TTM through Mar 2026 was 19.63%, a 897.0% decrease from a year earlier, with the FY2025 full-year figure at 2.74%, down 287.0% from the prior year.
• EBIT Margin for Q1 2026 stood at 2.44%, up from 2.21% in the prior quarter.
• Over the last five years, EBIT Margin for BAX reached as high as 38.27% in Q3 2024 and fell as low as 79.8% in Q3 2022.
• Historically, EBIT Margin has averaged 5.26% across 5 years, with a median of 4.93% in 2022.
• Across the five-year window, EBIT Margin plunged 9570 bps in 2022 and surged 7784 bps in 2023, its largest moves.
• Year by year, EBIT Margin stood at 8.33% in 2022, then surged by 384 bps to 23.67% in 2023, then soared by 47 bps to 34.83% in 2024, then sank by 94 bps to 2.21% in 2025, then increased by 11 bps to 2.44% in 2026.
• Per Business Quant data, the three most recent EBIT Margin figures were 2.44% in Q1 2026, 2.21% in Q1 2025, and 34.83% in Q4 2024.